Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNdUF5Wmh3SmV6Y1Y3a0FjMkJlX2lPZWt4QkJ6Unc0cVRlUzBXc0h1X2J2Y3YyVWVGT3NLNndPenZjTE5nb1hwdGtWeWdtRF9IU0ZPdFZQTHBSeGM5RTRBY2FOMlJVWmYtTENlT3FoX3RfQTN5VFRMTE9GZ2NLNV9PcnFrSWJJSFQ4OFRZT1JqMmdPd29uNF9LQXFBeXloa2JhNlpsSVlLMzlwLWtBeDZj?oc=5" target="_blank">Predictors Highlighted for Bleeding During Extended Apixaban for Cancer-Associated VTE</a>&nbsp;&nbsp;<font color="#6f6f6f">DocWireNews</font>
James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton
Michael Douglas confirms Charlie Sheen put ‘c---’ sign on Sean Young during Wall Street shoot
Gambhir: 'Bowlers' careers are at stake'
Tornado watches expire in SC; NWS tracked 2 confirmed tornadoes
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aaFFlX2l1V0I4OE90MnIwY2NfbWlxVW1mdDJGY1pvUll1VElzbXN0NTZKYjg3TE01SW9iRGphMFBkZXVRb21mQ2tXd2ZUVGs4ZERySVh4cEhRSTdwSnBV?oc=5" target="_blank">Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism</a>&nbsp;&nbsp;<font color="#6f6f6f">NEJM</font>
<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBaTEdTZlZBUGU2SkNid3NRYzlPcXdNTXdPME4wMXhNbDMzVVc4MnkwSURMUWFOM0hQZDZxQllTTHI0Mk1fOFd5Qzg5X05lc2pNT1NTaUY3LTZzckM5TXQ0bXNqcVQ1WDg0QkRiS2ctMVQwbHc?oc=5" target="_blank">Response by Yamashita et al to Letter Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)” | Circulation</a>&nbsp;&nbsp;<font color="#6f6f6f">American Heart Association Journals</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPN0ZxU0RBU0xpWjlYU0U1NlNmSkR4Y1VkZmdUaVRlcHl5WHJXc1l6YnZlZ2JnZklyNWtjblVud2g5R3dOSzl0bURvR3h6Q1d3cXN1dG5ZVHdma25tbDdrcHFSeG9MUkJvTXVqbU45emY4N19JNWF1TE4ta21KQzNtQmtPaDVXUUNvdDBiUTlTRFZFREE2T1NFRHFOczV5V0NjRFE?oc=5" target="_blank">API-CAT Trial Shows Reduced-Dose Eliquis Matches Full Dose in Preventing Venous Thromboembolism, Lowers Bleeding Risk in Cancer Patients</a>&nbsp;&nbsp;<font color="#6f6f6f">Applied Clinical Trials</font>
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE00c2ZpMzBlM1lPZ3JfUDltWmRzVkFfcWd6d2RBNVdKWG1HTmducDE1RW13YWx6TWlqRU53SW9EWFBBTHVJNkwwdmduZUNSSGg4XzFnV1RfWEFlNGJJMmdUR3VJT1Z0WGJQay1J?oc=5" target="_blank">Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview - Lele - 2026 - MedComm</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQT2RGT1dfN0dLMWZzeEFTZzdhNXg1LTFabHdSdnVOaS14SUhEUG1Pcm1CNGNwWHd0d3hNVzhfaFo5eWxScEFHUFhsWjlYVkFINXlCd0xCa0lkemVQWHczOVVfRE1WMHFRTV9YSzRiVlkycTUxdGpuRE1sRkFRV0hLV1NUbmpQT25ua1dfR3FR?oc=5" target="_blank">The impact of long-term low-dose ionizing radiation on human health: risks and protective measures</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZEc5Q04weFhRT0UzeER4UkRkankwZHAwQ1BEbmNhbDlId3FUa3JCaGhXSl9VZ3NWNUdPUTlwMmV4TnlEUWRoSmxpWEUtdmNtS3NOZHo1ZWN4Y25ncWtCWWhaWTBocGk4ZWk1TlR2bWtNTnRWUDVkbkE4VXRxZUVIaGZpSUFmclVIa1pz?oc=5" target="_blank">To thin, or not too thin: questions of anticoagulation for pulmonary hypertension</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE5FaFFvRENsbGVWYTZ4WjhmODVONmhTZXgtREZUZS10Nm1HUmR0Z1pDUlJwVTB2TWZwc0F1SzM4Q3g2VmNZQ1cycHZ4dlo5VGdvSDBOajN2dXBQa0NaNnpzbVZRZWduaXdLRHEweWxqNFQzWm54R0pLaUNoQjVUdw?oc=5" target="_blank">Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA</a>&nbsp;&nbsp;<font color="#6f6f6f">TCTMD.com</font>
<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE0tY2VEZHNGM1gwc1lSMEVLdU1Ua3dQYUZ5Y1FzMklMRFVubWZLVlE0VjUyQlU2Ukh3Tk9CSGREVzJ4MWJwUG1pOVRjZTBUaWJ5RE5BMFdNOXlBQ1FLMS0xcEZrNkZDVThqYmZBWjkyLWlTVEU?oc=5" target="_blank">Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation</a>&nbsp;&nbsp;<font color="#6f6f6f">MedPage Today</font>
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQUU92TWdEdl9SNFhZY1ZtTUJHUUZKWW5IN25MUkkxZXI4R3Q2U3QzZDhtUVV3UnlZQzdnNVIwbDlDZHJwNXRiRzFWWUVsX1JpYXVpakRhTVdqaDYtV2JvcnNFN2xxQWhEYXd1V0RCSVN6Uk11RTFRSXFaVHg0dGhZMTBqNUczNk5oem5RRHVQNHdtOVJvOEhPWFgtVU00bF9LMEdndm1vM20tX2NWY2ZlaTBB?oc=5" target="_blank">Reduced-dose apixaban noninferior to full dose for cancer-associated thrombosis</a>&nbsp;&nbsp;<font color="#6f6f6f">2 Minute Medicine</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TRFhqOTg4eVhaYVdnejkwTVpaRkl1QTJjd0dRMHN3R29ST2dzdkdjNG9BdU1xdDRPMXotc1l5QW03RHVaVE0takhCQmJEMnJfem1pcnlVSWR3S0Z1TjI0?oc=5" target="_blank">Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOM1ZTTlZBTTdHaDBiMVdMOGQwQXVwSVFuellxcmx2eHM2aFpRajNTdWZnc21PWUFPUWZlVDg2REZwX2Q3di1qYVI1Q2pjYmhsU0poS1UtR3ZGc09wQ3ZwNFpsNDdvRkZYY2p0aVdWOVREWGhHTnBYMFlxZ0JmLUJOX1BQa0lEOWNibGhPNHhjRTNSX3ZCbkhyRzFUSGNVV3g3eGc2STB6aw?oc=5" target="_blank">API-CAT Findings Support Existing NCCN Cancer-Associated VTE Guidance</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNUzJSN2xSTVBXcGVod19ONVFIWXkwbDdYM1B0MVF4cVJmTlR6MmxPVWlNZG1iMTd5QkdOZWx4R2thSk9kTnRBMFhxWEZoMXNKSWx5VWZ1X1ItcU0wSmE2bnRSUUxiM1NlOHJlOWhFdWFZWk5HM0JxUmdkeDlwY2VrZzlIS3IzZ3JVR1ZhMXJmdlQyWTdYSDg2RC1nZ1ZUZS1BUkFEOE1fQkwxMjVCdDlEM0xnNUc0LTVsQkptZkEwRHVENVZwWDE0?oc=5" target="_blank">Low-Dose vs Regular-Dose Apixaban for Prevention of VTE Recurrence in Patients With Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOUFBWdGY5Zl9YZzJBdVRWaUpFMXNMbjhfRGl1NXBlcURZaWRGaGhHLWI0cGlDdVlDc1NjUFNMY1NMMmpUV0hOajNLU1hPaUx1Rzl4bUpJVHZyQkZkVTdJbDdJaWc3N014U0w5SHdPTkhGNFNsd0hmem9jNEJqRVliT1lrczJpbUJGNXk0TTJvcld5d1VjZ21tRkRGa0RaVWFFakVBamdPU2I0djZJcl9hQ25tVThCbmw1N2VBUUdWMGFqSkVLREVYZHRnZWt2VXUzZ3M1b1VtZw?oc=5" target="_blank">Low-dose apixaban for extended anticoagulation may be option for preventing cancer-related VTE</a>&nbsp;&nbsp;<font color="#6f6f6f">Healio</font>
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNTDB3TnJNVHh5NV9zSHJ5TWxWRlY1NVVjQlJBeGQ4ZmdqeTF5RHdOYjJ3ZFJKZktYcEs5aUR3MzNiWVBkdGhabkZhZXZQa01vcjBvT014X2EwdFBYSzhzY0hURUtVSXg4Nm85cHZzZG42Y0lBUTgyWjY4elpycVJoQXBOMkJVWnIwODAyYy13elRwMlZhU1gxZA?oc=5" target="_blank">Low-Dose Apixaban Best for Long-Term Use in Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNbE1HQ0l1WkgycTZELVAzNncteDVaVXJpWVJtWFNNbHdLODNCaG42STZCUzVOcUUxaDNoSnl5TFgtYUJIeVI2b1VfVmRiSFRnU2JwcEdDaXB2alRIZVNtOF9DNVhGNTNDNnBuQlc5QmkxMHRtay1FcXk0NFJDaUFDODZhZVhRUXZpbDl0Z2QxZWM4VzlUWmR1QXZQbUZiWl9ZU244d3pTVXFxSUlyRUJELW1FUFpfZw?oc=5" target="_blank">Practice Change for Cancer Patients at Risk for Venous Thromboembolism</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology News Central</font>
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQNUZDNzR6SzhXYUY2QWRZZXlqUFE2ZDNqa1pPRVJrM0swSFBzUFJlZWc3eUFFVnlYdGRTWGNyRnkzT0xGWlNva29VaDZyVzY0enhuT0FHRzQ5QmVvT0J2bmNYRTFiZ3h0aHZGREp6MWwzVExGTEhHTjd1QTR5SkVfNE5jOVBORDl5cjR6VjBLQjd0VVlZ?oc=5" target="_blank">Low-Dose Apixiban Comparable to Full Dose for Preventing VTE Recurrence in Patients with Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">American College of Cardiology</font>
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQSUs3TTQydW1OWjF6SmhWQU1fUnBBTWxod2ZzRW1DbzZVRTdHNzVqR3NmdDdPMGYwVzlUQ1gtQ2FiT2Rxbkd1Vy1sUUt1bHVaMW1mWXFocFUybjN1MEpTemQ1TkNFbGpqdEpYdjI4cjhFcmhYLXh5U3EyeXRvZXQ0aUthUjQxWGN4dGdqajhSY0RIaE5tR3JaNGY0aFFTSWc?oc=5" target="_blank">Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT</a>&nbsp;&nbsp;<font color="#6f6f6f">TCTMD.com</font>
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxPcjhjMzdVaUF6b3dSS1NDdnc3TjFTdElweFh6ZEdSeEIxeWlyYXZCRHBRMnNQNjNjOEhIOHVick1sTWdTbEY3MmhjR0xSUUJ1TFRQVzIwSFJqSlB2eXA1X2RqanM3QkFWM0RZcGhjcnExZGtTUkZfQ3lPblVFeUZkTG5QUDVZcHZGSGJHOEJwWXZqTHlPTTdicUlOcjY0ODN5LWxpN2dabW9jWkZNSzJBaEU3cm5xTE5wSXQzUWxTSkRlZFRNYXQtVmxLTDljVmZsRWhxMk1lWlFsRjBzaFBjd3dHXzAzQQ?oc=5" target="_blank">ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNLXYtMk8tLTg2UlhjZHE5V05XTXRtbXVzOEpnMGFtWm5nYzdlSUdqWG80THRZeE41VGxfVUhUOVo2ZTFITTN0ejRuNFJteC0yRjdaMlQwZEpRNEpsbmVBZmxYUDkwVHpISEw3VllrRVRKQ2FjUnVrT2N4cVY1SlAycTdoVjJDNjgtei1IaEtoTjYteDkwTm9IRFFoSzdEcllqaFJtbDVDUHVrNklfUkdPdmRtbEx0T29TSGRCV010cmV1VXdERVBNcTFmM0pyVG8?oc=5" target="_blank">Reduced-Dose Apixaban Anticoagulation Noninferior to Full Dose in Prevention of Cancer-Associated VTE</a>&nbsp;&nbsp;<font color="#6f6f6f">DocWireNews</font>
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTFB2Wk9BUG9NQlFDT3d4U3l3d0FfS0t3NUpiYU5rOXdURU1HM0Q1RkVwVVFGYzM2QjJyUU5xSVh2aFFqOFpwQkkyZElHSFdyaDRZVlJIVGE0V2NKNGVMZVdzb3loSzFDNmgyNUdVRjdEbTZrMFZkZEZTTg?oc=5" target="_blank">Response by Yamashita et al to Letter Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”</a>&nbsp;&nbsp;<font color="#6f6f6f">American Heart Association Journals</font>
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE04ZzlkUmhDTmFiNldqdF90US1aREtUSzhZQ3RmU0h4ZUw4QmRTYThRYy1lOVBvNm81eVJLa25Rc1JaTkdJSW01WHZWYkI2dEQ0M083emhtbFJ2QVFqRnc?oc=5" target="_blank">Sebastian Szmit: The results of the API-CAT study have been published in NEJM</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncodaily</font>
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE4wQXpwQkM5MWFkWGxZWTRqeE9kWk9uZF9LLUNnRmUxaTdXWkZ0X0w3bWFWbFdNNDdvdGd0WHVobnV4T09NNDMxbTByTTgtZ1VQa3gtc0ppR091OTl2WmZmeEFSNWxWbWJSRUFxYUNTQng?oc=5" target="_blank">Practice-changing evidence from academic trials in VTE: COBRRA, RENOVE, and API-CAT | Vasa</a>&nbsp;&nbsp;<font color="#6f6f6f">Hogrefe eContent</font>
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxObWZ1RGxJX0hTb0xPOFZLa3FhODRqUlhlSGVzZkhSMlExVmNST05RNVZlMko1TVJ1c1JKTVhDVEdrYWRPSXJwQkJ0dWN2a2hvXzBxTlRtN3RqbEd6a0ROeHdlSjlNNDBpSUJ3cWNhWFk1LXIxUXJrb0c2TEUyMUVpX9IBlAFBVV95cUxPSnE0UWF5Sm5seXVWM2dkVk9UdXY5YUJyN0dzMXhvSnZucnBMdGRWaGRUYUpmaklJUVJVaVJ4WjZoSGd1a2NvTHdxVDR1WUpSXzlMUWNCdzBBZU1RMG54UDJUUWM5OFl6eXVCRDhVOG1LYWgyblVodmJTd2hqWGhNUDlOVGRjZU9tUTBHbHNaS1lNZXFr?oc=5" target="_blank">Peptron seeks Korea phase 1 trial for once-monthly semaglutide obesity drug - CHOSUNBIZ</a>&nbsp;&nbsp;<font color="#6f6f6f">Chosunbiz</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPWTk5blBqeEs3WFpEak4ybW0yalJ5RjktTjFDNjlULXN0Y2VFYTVrY3N4M3Y5V19XS212dWlCZUVNQ2RpTlF3eGY5bTI1WExnSWVfdkVTN3pJNUF0eF9JU2lCMzlUTW92YlliVFg5dlI5cUpJYVdYVHhlUWFnWU9DdnJnekx5MkR1WEtENS1n?oc=5" target="_blank">Efforts to Lower Cancer Drug Doses Gain Steam</a>&nbsp;&nbsp;<font color="#6f6f6f">National Cancer Institute (.gov)</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5jc2RuUkxQVU4yTGNzQzI1dTFNLTFHNnZNQ0xNV2M2M0ZZUklWSWpaMFFSRmNoaC1WYkgxX1RWVUdWdVk3YkZJX2RUN1JkNXZ1dmJfNDhuWVM5bUU0YlNZ?oc=5" target="_blank">Parenteral platforms for tunable, long-acting administration of a highly hydrophobic antiretroviral drug</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9fdFM3RDhQMVk5RnlEeDJ2MmJTdEhzMEdTVDE5T3dNdHFGQ012ek50Xy1ibTExb2ljdVNpMzVTS1BXOTdfcU12QkpNaTl2MEhVdXZ1N2lHUlZ3dkpvMVItbDU5WQ?oc=5" target="_blank">Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients - Du - 2025 - European Journal of Clinical Investigation</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZE13SWpQdUlEamNKSGExdEJmQi1jVU00aFZTckhtZXU3S3RoOTRiTzFUbVF2bjhobXgtU091RXJYRzluci1VN1J6ZzU5R3c4aUtISF9VUVBSeXBuWTVyNFJtMmpnVU9ST294WHdQc2p0ZHlQNGVaUkFMYTc3YXVvZVgzVzF4VE1idFB1TWlMN19XeVNqVW43czNOV3g5OEQyd3V4bTdGOEVmTFV6T1UwSFgycFduMk5VbU9yaUtCZFVSdw?oc=5" target="_blank">Eisai, Biogen Receive Extended FDA Review for Lecanemab Subcutaneous Starting Dose</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharm International</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOelFKUE53dFByTlp0MmxVR09ZX0taVFZsRUlmZVc0dmdNeVFBRUJZU2NrSWFRUzRzQkhBYlBPQlpWN1QxNy1TWkxqRG5oTFRWWmJ1SGx4bmdITWRpd01qcVBoYWEtcUJsQmtxQ3g1bmhneHFwazY2TXRIeG9fTHBHMlZVN3d5d2U3cXk4?oc=5" target="_blank">Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease: a Lancet Haematology Commission</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
<a href="https://news.google.com/rss/articles/CBMilwJBVV95cUxPcUFISkpBSW56TVJhQUx3aUI1ZjF0QkRUTXlJMk41d0xQVi1QNmtTeXBjUTdDSDc1bEgtY3ZJekd1VVg4ck53Q21IRDFhaTdXOTZmaEdnY0ljU2M1RVRDX0c4eFVSaTZOTkZOQi1GUkkzc3pMRlBNT1NLN0dVMkRndnpmTm12U2lvakdvT1JhS3o2MmVvR1dMSTNUa093aUl2MHYyd2ZiUFV5dUdmN29vNVMySXJjNEdraXdMdFBwMU5nUzlreUdZdDVUOTZSQ1Ytb3FqSUZrSExtODBZTGkxNUotSEZyM2pQMkFCVlhFYWc0OXBEVjZEcWVfRXBzZ3BlOGNyLWRaNVNJUzgtNjJWc2dRUDZoaEE?oc=5" target="_blank">Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings</a>&nbsp;&nbsp;<font color="#6f6f6f">National Academy of Medicine</font>